Global AT1 Receptor Antagonists Sales Market Report 2021

Publisher Name :
Date: 04-May-2021
No. of pages: 134
Inquire Before Buying

The global AT1 Receptor Antagonists market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global AT1 Receptor Antagonists market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Valsartan

- Telmisartan

- Losartan

- Irbesartan

- Azilsartan

- Olmesartan

Segment by Application

- Hypertension

- Cardiovascular Diseases

- Kidney Diseases

- Other

The AT1 Receptor Antagonists market is analysed and market size information is provided by regions (countries). Segment by Application, the AT1 Receptor Antagonists market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Pfizer

- Novartis

- Merck

- Astra Zeneca

- Jhonson and Johnson

- Eli Lilly

- Sanofi

- Bristol-Myers Squibb

- Bayer

- GSK

- Teva Pharmaceutical

Global AT1 Receptor Antagonists Sales Market Report 2021

Table of Contents
1 AT1 Receptor Antagonists Market Overview
1.1 AT1 Receptor Antagonists Product Scope
1.2 AT1 Receptor Antagonists Segment by Type
1.2.1 Global AT1 Receptor Antagonists Sales by Type (2016 & 2021 & 2027)
1.2.2 Valsartan
1.2.3 Telmisartan
1.2.4 Losartan
1.2.5 Irbesartan
1.2.6 Azilsartan
1.2.7 Olmesartan
1.3 AT1 Receptor Antagonists Segment by Application
1.3.1 Global AT1 Receptor Antagonists Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hypertension
1.3.3 Cardiovascular Diseases
1.3.4 Kidney Diseases
1.3.5 Other
1.4 AT1 Receptor Antagonists Market Estimates and Forecasts (2016-2027)
1.4.1 Global AT1 Receptor Antagonists Market Size in Value Growth Rate (2016-2027)
1.4.2 Global AT1 Receptor Antagonists Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global AT1 Receptor Antagonists Price Trends (2016-2027)
2 AT1 Receptor Antagonists Estimates and Forecasts by Region
2.1 Global AT1 Receptor Antagonists Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global AT1 Receptor Antagonists Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global AT1 Receptor Antagonists Sales Market Share by Region (2016-2021)
2.2.2 Global AT1 Receptor Antagonists Revenue Market Share by Region (2016-2021)
2.3 Global AT1 Receptor Antagonists Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global AT1 Receptor Antagonists Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global AT1 Receptor Antagonists Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America AT1 Receptor Antagonists Estimates and Projections (2016-2027)
2.4.2 Europe AT1 Receptor Antagonists Estimates and Projections (2016-2027)
2.4.3 China AT1 Receptor Antagonists Estimates and Projections (2016-2027)
2.4.4 Japan AT1 Receptor Antagonists Estimates and Projections (2016-2027)
2.4.5 Southeast Asia AT1 Receptor Antagonists Estimates and Projections (2016-2027)
2.4.6 India AT1 Receptor Antagonists Estimates and Projections (2016-2027)
3 Global AT1 Receptor Antagonists Competition Landscape by Players
3.1 Global Top AT1 Receptor Antagonists Players by Sales (2016-2021)
3.2 Global Top AT1 Receptor Antagonists Players by Revenue (2016-2021)
3.3 Global AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in AT1 Receptor Antagonists as of 2020)
3.4 Global AT1 Receptor Antagonists Average Price by Company (2016-2021)
3.5 Manufacturers AT1 Receptor Antagonists Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global AT1 Receptor Antagonists Market Size by Type
4.1 Global AT1 Receptor Antagonists Historic Market Review by Type (2016-2021)
4.1.1 Global AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
4.1.2 Global AT1 Receptor Antagonists Revenue Market Share by Type (2016-2021)
4.1.3 Global AT1 Receptor Antagonists Price by Type (2016-2021)
4.2 Global AT1 Receptor Antagonists Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global AT1 Receptor Antagonists Sales Forecast by Type (2022-2027)
4.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Type (2022-2027)
4.2.3 Global AT1 Receptor Antagonists Price Forecast by Type (2022-2027)
5 Global AT1 Receptor Antagonists Market Size by Application
5.1 Global AT1 Receptor Antagonists Historic Market Review by Application (2016-2021)
5.1.1 Global AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
5.1.2 Global AT1 Receptor Antagonists Revenue Market Share by Application (2016-2021)
5.1.3 Global AT1 Receptor Antagonists Price by Application (2016-2021)
5.2 Global AT1 Receptor Antagonists Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global AT1 Receptor Antagonists Sales Forecast by Application (2022-2027)
5.2.2 Global AT1 Receptor Antagonists Revenue Forecast by Application (2022-2027)
5.2.3 Global AT1 Receptor Antagonists Price Forecast by Application (2022-2027)
6 North America AT1 Receptor Antagonists Market Facts & Figures
6.1 North America AT1 Receptor Antagonists Sales by Company
6.1.1 North America AT1 Receptor Antagonists Sales by Company (2016-2021)
6.1.2 North America AT1 Receptor Antagonists Revenue by Company (2016-2021)
6.2 North America AT1 Receptor Antagonists Sales Breakdown by Type
6.2.1 North America AT1 Receptor Antagonists Sales Breakdown by Type (2016-2021)
6.2.2 North America AT1 Receptor Antagonists Sales Breakdown by Type (2022-2027)
6.3 North America AT1 Receptor Antagonists Sales Breakdown by Application
6.3.1 North America AT1 Receptor Antagonists Sales Breakdown by Application (2016-2021)
6.3.2 North America AT1 Receptor Antagonists Sales Breakdown by Application (2022-2027)
7 Europe AT1 Receptor Antagonists Market Facts & Figures
7.1 Europe AT1 Receptor Antagonists Sales by Company
7.1.1 Europe AT1 Receptor Antagonists Sales by Company (2016-2021)
7.1.2 Europe AT1 Receptor Antagonists Revenue by Company (2016-2021)
7.2 Europe AT1 Receptor Antagonists Sales Breakdown by Type
7.2.1 Europe AT1 Receptor Antagonists Sales Breakdown by Type (2016-2021)
7.2.2 Europe AT1 Receptor Antagonists Sales Breakdown by Type (2022-2027)
7.3 Europe AT1 Receptor Antagonists Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China AT1 Receptor Antagonists Market Facts & Figures
8.1 China AT1 Receptor Antagonists Sales by Company
8.1.1 China AT1 Receptor Antagonists Sales by Company (2016-2021)
8.1.2 China AT1 Receptor Antagonists Revenue by Company (2016-2021)
8.2 China AT1 Receptor Antagonists Sales Breakdown by Type
8.2.1 China AT1 Receptor Antagonists Sales Breakdown by Type (2016-2021)
8.2.2 China AT1 Receptor Antagonists Sales Breakdown by Type (2022-2027)
8.3 China AT1 Receptor Antagonists Sales Breakdown by Application
8.3.1 China 154 Sales Breakdown by Application (2016-2021)
8.3.2 China 154 Sales Breakdown by Application (2022-2027)
9 Japan AT1 Receptor Antagonists Market Facts & Figures
9.1 Japan AT1 Receptor Antagonists Sales by Company
9.1.1 Japan AT1 Receptor Antagonists Sales by Company (2016-2021)
9.1.2 Japan AT1 Receptor Antagonists Revenue by Company (2016-2021)
9.2 Japan AT1 Receptor Antagonists Sales Breakdown by Type
9.2.1 Japan AT1 Receptor Antagonists Sales Breakdown by Type (2016-2021)
9.2.2 Japan AT1 Receptor Antagonists Sales Breakdown by Type (2022-2027)
9.3 Japan AT1 Receptor Antagonists Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia AT1 Receptor Antagonists Market Facts & Figures
10.1 Southeast Asia AT1 Receptor Antagonists Sales by Company
10.1.1 Southeast Asia AT1 Receptor Antagonists Sales by Company (2016-2021)
10.1.2 Southeast Asia AT1 Receptor Antagonists Revenue by Company (2016-2021)
10.2 Southeast Asia AT1 Receptor Antagonists Sales Breakdown by Type
10.2.1 Southeast Asia AT1 Receptor Antagonists Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia AT1 Receptor Antagonists Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia AT1 Receptor Antagonists Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India AT1 Receptor Antagonists Market Facts & Figures
11.1 India AT1 Receptor Antagonists Sales by Company
11.1.1 India AT1 Receptor Antagonists Sales by Company (2016-2021)
11.1.2 India AT1 Receptor Antagonists Revenue by Company (2016-2021)
11.2 India AT1 Receptor Antagonists Sales Breakdown by Type
11.2.1 India AT1 Receptor Antagonists Sales Breakdown by Type (2016-2021)
11.2.2 India AT1 Receptor Antagonists Sales Breakdown by Type (2022-2027)
11.3 India AT1 Receptor Antagonists Sales Breakdown by Application
11.3.1 India AT1 Receptor Antagonists Sales Breakdown by Application (2016-2021)
11.3.2 India AT1 Receptor Antagonists Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in AT1 Receptor Antagonists Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer AT1 Receptor Antagonists Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis AT1 Receptor Antagonists Products Offered
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck AT1 Receptor Antagonists Products Offered
12.3.5 Merck Recent Development
12.4 Astra Zeneca
12.4.1 Astra Zeneca Corporation Information
12.4.2 Astra Zeneca Business Overview
12.4.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Astra Zeneca AT1 Receptor Antagonists Products Offered
12.4.5 Astra Zeneca Recent Development
12.5 Jhonson and Johnson
12.5.1 Jhonson and Johnson Corporation Information
12.5.2 Jhonson and Johnson Business Overview
12.5.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Jhonson and Johnson AT1 Receptor Antagonists Products Offered
12.5.5 Jhonson and Johnson Recent Development
12.6 Eli Lilly
12.6.1 Eli Lilly Corporation Information
12.6.2 Eli Lilly Business Overview
12.6.3 Eli Lilly AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Eli Lilly AT1 Receptor Antagonists Products Offered
12.6.5 Eli Lilly Recent Development
12.7 Sanofi
12.7.1 Sanofi Corporation Information
12.7.2 Sanofi Business Overview
12.7.3 Sanofi AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanofi AT1 Receptor Antagonists Products Offered
12.7.5 Sanofi Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Corporation Information
12.8.2 Bristol-Myers Squibb Business Overview
12.8.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bristol-Myers Squibb AT1 Receptor Antagonists Products Offered
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Business Overview
12.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bayer AT1 Receptor Antagonists Products Offered
12.9.5 Bayer Recent Development
12.10 GSK
12.10.1 GSK Corporation Information
12.10.2 GSK Business Overview
12.10.3 GSK AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.10.4 GSK AT1 Receptor Antagonists Products Offered
12.10.5 GSK Recent Development
12.11 Teva Pharmaceutical
12.11.1 Teva Pharmaceutical Corporation Information
12.11.2 Teva Pharmaceutical Business Overview
12.11.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Pharmaceutical AT1 Receptor Antagonists Products Offered
12.11.5 Teva Pharmaceutical Recent Development
13 AT1 Receptor Antagonists Manufacturing Cost Analysis
13.1 AT1 Receptor Antagonists Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of AT1 Receptor Antagonists
13.4 AT1 Receptor Antagonists Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 AT1 Receptor Antagonists Distributors List
14.3 AT1 Receptor Antagonists Customers
15 Market Dynamics
15.1 AT1 Receptor Antagonists Market Trends
15.2 AT1 Receptor Antagonists Drivers
15.3 AT1 Receptor Antagonists Market Challenges
15.4 AT1 Receptor Antagonists Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global AT1 Receptor Antagonists Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global AT1 Receptor Antagonists Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global AT1 Receptor Antagonists Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global AT1 Receptor Antagonists Sales (K Units) by Region (2016-2021)
Table 5. Global AT1 Receptor Antagonists Sales Market Share by Region (2016-2021)
Table 6. Global AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global AT1 Receptor Antagonists Revenue Share by Region (2016-2021)
Table 8. Global AT1 Receptor Antagonists Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global AT1 Receptor Antagonists Sales Market Share Forecast by Region (2022-2027)
Table 10. Global AT1 Receptor Antagonists Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global AT1 Receptor Antagonists Revenue Share Forecast by Region (2022-2027)
Table 12. Global AT1 Receptor Antagonists Sales (K Units) of Key Companies (2016-2021)
Table 13. Global AT1 Receptor Antagonists Sales Share by Company (2016-2021)
Table 14. Global AT1 Receptor Antagonists Revenue (US$ Million) by Company (2016-2021)
Table 15. Global AT1 Receptor Antagonists Revenue Share by Company (2016-2021)
Table 16. Global AT1 Receptor Antagonists by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AT1 Receptor Antagonists as of 2020)
Table 17. Global AT1 Receptor Antagonists Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers AT1 Receptor Antagonists Manufacturing Sites and Area Served
Table 19. Manufacturers AT1 Receptor Antagonists Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global AT1 Receptor Antagonists Sales (K Units) by Type (2016-2021)
Table 22. Global AT1 Receptor Antagonists Sales Share by Type (2016-2021)
Table 23. Global AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global AT1 Receptor Antagonists Price (USD/Unit) by Type (2016-2021)
Table 25. Global AT1 Receptor Antagonists Sales Share by Type (2022-2027)
Table 26. Global AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global AT1 Receptor Antagonists Revenue Share by Type (2022-2027)
Table 28. Global AT1 Receptor Antagonists Price (USD/Unit) by Type (2022-2027)
Table 29. Global AT1 Receptor Antagonists Sales (K Units) by Application (2016-2021)
Table 30. Global AT1 Receptor Antagonists Sales Share by Application (2016-2021)
Table 31. Global AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global AT1 Receptor Antagonists Price (USD/Unit) by Application (2016-2021)
Table 33. Global AT1 Receptor Antagonists Sales (K Units) by Application (2022-2027)
Table 34. Global AT1 Receptor Antagonists Sales Share by Application (2022-2027)
Table 35. Global AT1 Receptor Antagonists Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global AT1 Receptor Antagonists Revenue Share by Application (2022-2027)
Table 37. Global AT1 Receptor Antagonists Price (USD/Unit) by Application (2022-2027)
Table 38. North America AT1 Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 39. North America AT1 Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 40. North America AT1 Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America AT1 Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 42. North America AT1 Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 43. North America AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 44. North America AT1 Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 45. North America AT1 Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 46. North America AT1 Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 47. North America AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 48. North America AT1 Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 49. North America AT1 Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 50. Europe AT1 Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 51. Europe AT1 Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 52. Europe AT1 Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe AT1 Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 54. Europe AT1 Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 55. Europe AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 56. Europe AT1 Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 57. Europe AT1 Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 58. Europe AT1 Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 59. Europe AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 60. Europe AT1 Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 61. Europe AT1 Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 62. China AT1 Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 63. China AT1 Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 64. China AT1 Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 65. China AT1 Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 66. China AT1 Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 67. China AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 68. China AT1 Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 69. China AT1 Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 70. China AT1 Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 71. China AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 72. China AT1 Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 73. China AT1 Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 74. Japan AT1 Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 75. Japan AT1 Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 76. Japan AT1 Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan AT1 Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 78. Japan AT1 Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 79. Japan AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 80. Japan AT1 Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 81. Japan AT1 Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 82. Japan AT1 Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 83. Japan AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 84. Japan AT1 Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 85. Japan AT1 Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia AT1 Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia AT1 Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia AT1 Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia AT1 Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia AT1 Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia AT1 Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia AT1 Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 98. India AT1 Receptor Antagonists Sales (K Units) by Company (2016-2021)
Table 99. India AT1 Receptor Antagonists Sales Market Share by Company (2016-2021)
Table 100. India AT1 Receptor Antagonists Revenue by Company (2016-2021) & (US$ Million)
Table 101. India AT1 Receptor Antagonists Revenue Market Share by Company (2016-2021)
Table 102. India AT1 Receptor Antagonists Sales by Type (2016-2021) & (K Units)
Table 103. India AT1 Receptor Antagonists Sales Market Share by Type (2016-2021)
Table 104. India AT1 Receptor Antagonists Sales by Type (2022-2027) & (K Units)
Table 105. India AT1 Receptor Antagonists Sales Market Share by Type (2022-2027)
Table 106. India AT1 Receptor Antagonists Sales by Application (2016-2021) & (K Units)
Table 107. India AT1 Receptor Antagonists Sales Market Share by Application (2016-2021)
Table 108. India AT1 Receptor Antagonists Sales by Application (2022-2027) & (K Units)
Table 109. India AT1 Receptor Antagonists Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer AT1 Receptor Antagonists Product
Table 114. Pfizer Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Novartis AT1 Receptor Antagonists Product
Table 119. Novartis Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Merck AT1 Receptor Antagonists Product
Table 124. Merck Recent Development
Table 125. Astra Zeneca Corporation Information
Table 126. Astra Zeneca Description and Business Overview
Table 127. Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Astra Zeneca AT1 Receptor Antagonists Product
Table 129. Astra Zeneca Recent Development
Table 130. Jhonson and Johnson Corporation Information
Table 131. Jhonson and Johnson Description and Business Overview
Table 132. Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Jhonson and Johnson AT1 Receptor Antagonists Product
Table 134. Jhonson and Johnson Recent Development
Table 135. Eli Lilly Corporation Information
Table 136. Eli Lilly Description and Business Overview
Table 137. Eli Lilly AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Eli Lilly AT1 Receptor Antagonists Product
Table 139. Eli Lilly Recent Development
Table 140. Sanofi Corporation Information
Table 141. Sanofi Description and Business Overview
Table 142. Sanofi AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Sanofi AT1 Receptor Antagonists Product
Table 144. Sanofi Recent Development
Table 145. Bristol-Myers Squibb Corporation Information
Table 146. Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Bristol-Myers Squibb Description and Business Overview
Table 148. Bristol-Myers Squibb AT1 Receptor Antagonists Product
Table 149. Bristol-Myers Squibb Recent Development
Table 150. Bayer Corporation Information
Table 151. Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Bayer Description and Business Overview
Table 153. Bayer AT1 Receptor Antagonists Product
Table 154. Bayer Recent Development
Table 155. GSK Corporation Information
Table 156. GSK Description and Business Overview
Table 157. GSK AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. GSK AT1 Receptor Antagonists Product
Table 159. GSK Recent Development
Table 160. Teva Pharmaceutical Corporation Information
Table 161. Teva Pharmaceutical Description and Business Overview
Table 162. Teva Pharmaceutical AT1 Receptor Antagonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Teva Pharmaceutical AT1 Receptor Antagonists Product
Table 164. Teva Pharmaceutical Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. AT1 Receptor Antagonists Distributors List
Table 168. AT1 Receptor Antagonists Customers List
Table 169. AT1 Receptor Antagonists Market Trends
Table 170. AT1 Receptor Antagonists Market Drivers
Table 171. AT1 Receptor Antagonists Market Challenges
Table 172. AT1 Receptor Antagonists Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. AT1 Receptor Antagonists Product Picture
Figure 2. Global AT1 Receptor Antagonists Sales Market Share by Type in 2021 & 2027
Figure 3. Valsartan Product Picture
Figure 4. Telmisartan Product Picture
Figure 5. Losartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Azilsartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Global AT1 Receptor Antagonists Sales Market Share by Application in 2021 & 2027
Figure 10. Hypertension Examples
Figure 11. Cardiovascular Diseases Examples
Figure 12. Kidney Diseases Examples
Figure 13. Other Examples
Figure 14. Global AT1 Receptor Antagonists Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global AT1 Receptor Antagonists Sales Growth Rate (2016-2027) & (US$ Million)
Figure 16. Global AT1 Receptor Antagonists Sales (K Units) Growth Rate (2016-2027)
Figure 17. Global AT1 Receptor Antagonists Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 18. Global AT1 Receptor Antagonists Revenue Market Share by Region: 2016 VS 2021
Figure 19. Global AT1 Receptor Antagonists Revenue Market Share by Region: 2021 VS 2027
Figure 20. North America AT1 Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. North America AT1 Receptor Antagonists Sales (K Units) Growth Rate (2016-2027)
Figure 22. Europe AT1 Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Europe AT1 Receptor Antagonists Sales (Million USD) Growth Rate (2016-2027)
Figure 24. China AT1 Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. China AT1 Receptor Antagonists Sales (Million USD) and Growth Rate (2016-2027)
Figure 26. Japan AT1 Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Japan AT1 Receptor Antagonists Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia AT1 Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Southeast Asia AT1 Receptor Antagonists Sales (Million USD) Growth Rate (2016-2027)
Figure 30. India AT1 Receptor Antagonists Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. India AT1 Receptor Antagonists Sales (Million USD) Growth Rate (2016-2027)
Figure 32. Global 5 Largest AT1 Receptor Antagonists Players Market Share by Revenue in AT1 Receptor Antagonists: 2016 & 2020
Figure 33. AT1 Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 34. Global AT1 Receptor Antagonists Revenue Share by Type (2016-2021)
Figure 35. Global AT1 Receptor Antagonists Revenue Growth Rate by Type in 2016 & 2020
Figure 36. Global AT1 Receptor Antagonists Revenue Share by Application (2016-2021)
Figure 37. Global AT1 Receptor Antagonists Revenue Growth Rate by Application in 2016 & 2020
Figure 38. North America AT1 Receptor Antagonists Sales Market Share by Type in 2020
Figure 39. North America AT1 Receptor Antagonists Sales Market Share by Application in 2020
Figure 40. Europe AT1 Receptor Antagonists Sales Market Share by Type in 2020
Figure 41. Europe AT1 Receptor Antagonists Sales Market Share by Application in 2020
Figure 42. China AT1 Receptor Antagonists Sales Market Share by Type in 2020
Figure 43. China AT1 Receptor Antagonists Sales Market Share by Application in 2020
Figure 44. Japan AT1 Receptor Antagonists Sales Market Share by Type in 2020
Figure 45. Japan AT1 Receptor Antagonists Sales Market Share by Application in 2020
Figure 46. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Type in 2020
Figure 47. Southeast Asia AT1 Receptor Antagonists Sales Market Share by Application in 2020
Figure 48. India AT1 Receptor Antagonists Sales Market Share by Type in 2020
Figure 49. India AT1 Receptor Antagonists Sales Market Share by Application in 2020
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of AT1 Receptor Antagonists
Figure 52. Manufacturing Process Analysis of AT1 Receptor Antagonists
Figure 53. AT1 Receptor Antagonists Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Exe
  • Global Aspirin Enteric-Coated Tablets Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 120
    The global Aspirin Enteric-Coated Tablets market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aspirin Enteric-Coated Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 81mg/Pc - 100mg......
  • Global Glucose Injection Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 113
    The global Glucose Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Glucose Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 5% Injection - 10% Injection - 50%......
  • Global Recombinant Peptide Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 119
    The global Recombinant Peptide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Peptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Glucagon - Calcitonin - Other......
  • Global Sufentanil (API) Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 119
    The global Sufentanil (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sufentanil (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Purity 98% - Purity 99% Segm......
  • Global Human Fibrinogen Concentrate Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 119
    The global Human Fibrinogen Concentrate market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Fibrinogen Concentrate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 0.5g - 1.0g ......
  • Global Influenza Drugs Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 143
    The global Influenza Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Zanamivir - Oseltamivir Phosphate - Pe......
  • Global Pet Medication Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 142
    The global Pet Medication market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pet Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Antibiotics - Antifungal - Flea Products......
  • Global Barrier Membranes Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 146
    The global Barrier Membranes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Barrier Membranes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Resorbable Membranes - Non-resorbable Mem......
  • Global Growth Hormone Drug Sales Market Report 2021
    Published: 05-May-2021        Price: US 4000 Onwards        Pages: 128
    The global Growth Hormone Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Growth Hormone Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Norditropin - Genotropin - Hum......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs